Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Y-mAbs Therapeutics | YMAB | May 30, 2024 | 12.01 | -2.12 |
Yalla ADR | YALA | May 30, 2024 | 4.79 | +0.21 |
Yatra Online | YTRA | May 30, 2024 | 1.61 | +0.63 |
Yatsen ADR | YSG | May 30, 2024 | 3.38 | +7.30 |
Yelp | YELP | May 30, 2024 | 36.52 | +0.55 |
YETI | YETI | May 30, 2024 | 39.80 | +2.52 |
Yext | YEXT | May 30, 2024 | 5.00 | +1.83 |
Yield10 Bioscience | YTEN | May 30, 2024 | 5.26 | 0.00 |
Yieldshares High Income ETF | YYY | May 30, 2024 | 11.79 | -0.76 |
Yiren Digital ADR | YRD | May 30, 2024 | 4.87 | +2.53 |
York Water | YORW | May 30, 2024 | 36.13 | +1.40 |
Yoshiharu Global A | YOSH | May 30, 2024 | 3.95 | -1.13 |
Yoshitsu ADR | TKLF | May 30, 2024 | 0.25 | +1.89 |
Yotta Acquisition | YOTA | May 30, 2024 | 10.90 | 0.00 |
Yotta Acquisition Unit | YOTAU | May 30, 2024 | 11.00 | 0.00 |
Youdao A ADR | DAO | May 30, 2024 | 3.82 | +2.14 |
YPF Sociedad Anonima ADR | YPF | May 30, 2024 | 23.91 | +6.46 |
YS Biopharma | YS | May 30, 2024 | 1.02 | 0.00 |
Yum China | YUMC | May 30, 2024 | 35.47 | +1.78 |
Yum! Brands | YUM | May 30, 2024 | 134.84 | +0.13 |
Yunhong Green CTI | YHGJ | May 30, 2024 | 1.16 | 0.00 |
Yunji ADR | YJ | May 30, 2024 | 0.68 | -8.57 |
YY Group Holding | YYGH | May 30, 2024 | 1.12 | 0.00 |
Zai Lab ADR | ZLAB | May 30, 2024 | 18.19 | +1.28 |
Zalatoris II Acquisition | ZLS | May 30, 2024 | 10.94 | 0.00 |
Zapata Computing | ZPTA | May 30, 2024 | 0.81 | 0.00 |
Zapp Electric Vehicles Group | ZAPP | May 30, 2024 | 0.94 | -1.06 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | May 30, 2024 | 43.70 | +0.25 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | May 30, 2024 | 59.31 | +1.72 |
Zebra Technologies A | ZBRA | May 30, 2024 | 316.62 | -0.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.